Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> JOHNSON & JOHNSON Latest News

19 HOURS AGO - TheStreet

A Must Read - Share

Johnson & Johnson (JNJ) Stock Rises Today Following Texas Lawsuit Dismissal

NEW YORK (TheStreet) -- Johnson & Johnson shares are up 0.3% to $102.94 on Friday after the consumer products manufacturer won a lawsuit brought against it by a Texas woman who sought damages for what she claimed was a faulty metal on metal hip implant that poisoned her. The jury unanimously ruled in favor of Johnson & Johnson finding that ...

Tags: Johnson & Johnson (JNJ) Stock Rises Today Following Texas Lawsuit Dismissal,  Johnson & Johnson Latest News

OCT 24, 2014 - Wall Street Journal

A Must Read - Share

J&J Unit Wins Texas Suit Regarding All-Metal Hip Implant

Johnson & Johnson received a favorable verdict Thursday from a Texas jury in a trial regarding the company’s all-metal hip-implant product.

Tags: J&J Unit Wins Texas Suit Regarding All-Metal Hip Implant,  Johnson & Johnson Latest News

OCT 22, 2014 - Fortune magazine

A Must Read - Share

Johnson & Johnson boosts Ebola vaccine efforts

Dr. Paul Stoffels, Chief Scientific Officer of Johnson & Johnson, says they have produced a 'significant number' of Ebola vaccines and will start clinical testing in humans in January.

Tags: Johnson & Johnson boosts Ebola vaccine efforts,  Johnson & Johnson Latest News

OCT 22, 2014 - TheStreet

A Must Read - Share

J&J Sees 250,000 Ebola Vaccine Doses Ready for Trials By May

Johnson & Johnson plans to roll out an Ebola vaccine it is working on developing for clinical trials by May.

Tags: J&J Sees 250,000 Ebola Vaccine Doses Ready for Trials By May,  Johnson & Johnson Latest News

OCT 22, 2014 - Wall Street Journal

A Must Read - Share

J&J to Test Ebola Vaccine in January

Johnson & Johnson said it would begin testing an Ebola-virus vaccine in humans in January and could have 250,000 doses available in May.

Tags: J&J to Test Ebola Vaccine in January,  Johnson & Johnson Latest News